The responses of extrinsic fibroblasts infiltrating the devitalised patellar tendon to IL-1β are different from those of normal tendon fibroblasts

Journal of Bone and Joint Surgery - Series B

Volumn 89, Issue 9, 2007, Pages 1261-1267

  Tohyama, H ^a   Yasuda, K ^a   Uchida, H ^a,b   Nishihira, J ^a,c  

^a HOKKAIDO UNIVERSITY   (Japan)

^b TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c HOKKAIDO INFORMATION UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE 3; INTERLEUKIN 1BETA; MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR BB; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CYTOKINE PRODUCTION; FIBROBLAST; FREEZE THAWING; GENE EXPRESSION; GENE OVEREXPRESSION; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LIGAMENT SURGERY; MALE; NONHUMAN; NORTHERN BLOTTING; PATELLA TENDON; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TENDON GRAFT; TISSUE REPAIR;

ANIMALS; BLOTTING, NORTHERN; FIBROBLASTS; INTERLEUKIN-1; MATRIX METALLOPROTEINASE 13; PATELLAR LIGAMENT; PLATELET-DERIVED GROWTH FACTOR; RATS; RATS, WISTAR; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA;

EID: 35948977011     PISSN: 0301620X     EISSN: None     Source Type: Journal    
DOI: 10.1302/0301-620X.89B9.18053     Document Type: Article

References (32)

1. Arnoczky SP, Tarvin GB, Marshall JL. Anterior cruciate ligament replacement using patellar tendon: an evaluation of graft revascularization in the dog. J Bone Joint Surg [Am] 1982;64-A:217-24.
2. Kleiner JB, Amiel D, Roux RD, Akeson WH. Origin of replacement cells for the anterior cruciate ligament autograft. J Orthop Res 1986;4:466-74.
3. Amiel D, Kleiner JB, Akeson WH. The natural history of the anterior cruciate ligament autograft of patellar tendon origin. Am J Sports Med 1986;14:449-62.
4. Hsu C, Chang J. Clinical implications of growth factors in flexor tendon wound healing. J Hand Surg [Am] 2004;29:551-63.
5. Marui T, Niyibizi C, Georgescu HI, et al. Effect of growth factors on matrix synthesis by ligament fibroblasts. J Orthop Res 1997;15:18-23.
6. Chang YC, Yang SF, Lai CC, Liu JY, Hsieh YS. Regulations of matrix metalloproteinase production by cytokines, pharmacological agents and periodontal pathogens in human peridontal ligament fibroblasts cultures. J Peridontal Res 2002;37:196-203.
7. Ikema Y, Tohyama H, Nakamura H, Kanaya F, Yasuda K. Growth kinetics and integrin expression of fibroblasts infiltrating devitalised patellar tendons are different from those of intrinsic fibroblasts. J Bone Joint Surg [Br] 2005;87-B:1689-93.
8. Tohyama H, Yasuda K, Uchida H. Is the increase in type III collagen of the patellar tendon graft after ligament reconstruction really caused by "ligamentization" of the graft? Knee Surg Sports Traumatol Arthrosc 2006;14:1270-77.
9. Knauper V, Will H, Lopez-Otin C, et al. Cellular mechanisms for human procollagenase-3 (MMP-13) activation: evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme. J Biol Chem 1996;271:17124-31.
10. Freije JM, Diez-Itza I, Balbin M, et al. Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. J Biol Chem 1994;269:16766-73.
11. Mauviel A. Cytokine regulation of metalloproteinase gene expression. J Cell Biochem 1993;53:288-95.
12. Cao Q, Mak KM, Lieber CS. Dilinoleoylphosphatidylcholine prevents transforming growth factor-beta1-mediated collagen accumulation in cultured rat hepatic stellate cells. J Lab Clin Med 2003;139:202-10.
13. Tsuzaki M, Guyton G, Garrett W, et al. IL-1 beta induces COX2, MMP-1, -3 and -13, ADAMTS-4, IL-1 beta and IL-6 in human tendon cells. J Orthop Res 2003;21:256-64.
14. Arakawa M, Hatamochi A, Mori Y, et al. Reduced collagenase gene expression in fibroblasts from hypertrophic scar tissue. Br J Dermatol 1996;134:863-8.
15. Dasu MR, Hawkins HK, Barrow RE, Xue H, Herndon DN. Gene expression profiles from hypertrophic scar fibroblasts before and after IL-6 stimulation. J Pathol 2004;202:476-85.
16. Blaine TA, Kim YS, Voloshin I, et al. The molecular pathophysiology of subacromial bursitis in rotator cuff disease. J Shoulder Elbow Surg 2005;14(Suppl 1):84-9.
17. Gotoh M, Hamada K, Yamakawa H, et al. Significance of granulation tissue in torn supraspinatus insertions: an immunohistochemical study with antibodies against interleukin-1 beta, cathepsin D, and matric metalloprotease-1. J Orthop Res 1997;15:33-9.
18. Gotoh M, Hamada K, Yamakawa H, et al. Perforation of rotator cuff increases interleukin 1beta production in the synovium of glenohumeral joint in rotator cuff diseases. J Rheumatol 2000;27:2886-92.
19. Sakai H, Fujita K, Sakai Y, Mizuno K. Immunolocalization of cytokines and growth factors in subacromial bursa of rotator cuff tear patients. Kobe J Med Sci 2001;47:25-34.
20. Fahey TJ 3rd, Sherry B, Tracey KJ, et al. Cytokine production in a model of wound healing: the appearance of MIP-1, MIP-2, cachectin/TNF and IL-1. Cytokine 1990;2:92-9.
21. Grellner W, Georg T, Wilske J. Quantitative analysis of proinflammatory cytokines (IL-1beta, IL-6, TNF-alpha) in human skin wounds. Forensic Sci Int 2000;113:251-64.
22. Kondo T, Ohshima T. The dynamics of inflammatory cytokines in the healing process of mouse skin wound: a preliminary study for possible wound age determination. Int J Legal Med 1996;108:231-6.
23. Neta R, Oppenheim JJ. Why should internists be interested in interleukin-1? Ann Intern Med 1988;109:1-3.
24. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 1996;87:2095-147.
25. Nagineni CN, Amiel D, Green MH, Berchuck M, Akeson WH. Characterization of the intrinsic properties of the anterior cruciate and medial collateral ligament cells: an in vitro cell culture study. J Orthop Res 1992;10:465-75.
26. Hannafin JA, Attia ET, Warren RF, Bhargava MM. Characterization of chemotactic migration and growth kinetics of canine knee ligament fibroblasts. J Orthop Res 1999;17:398-404.
27. Archambault J, Tsuzaki M, Herzog W, Banes AJ. Stretch and interleukin-1 beta induce matrix metalloproteinase in rabbit tendon cells in vitro. J Orthop Res 2002;20:36-9.
28. Chan BP, Chan KM, Maffulli N, Webb S, Lee KK. Effect of basic fibroblast growth factor: an in vitro study of tendon healing. Clin Orthop 1997;342:239-47.
29. Sadeghi M, Daniel V, Naujokat C, Weimer R, Opelz G. Strikingly higher interleukin (IL)-1alpha, IL-1beta and soluble interleukin-1 receptor antagonist (sIL-1RA) but similar IL-2, IL-3, IL-4, IL-6, sIL-6R, IL-10, tumour necrosis factor (TNF)-alpha, transforming growth factor (TGF)-beta and interferon IFN-gamma urine levels in healthy females compared to healthy males: protection against urinary tract injury? Clin Exp Immunol 2005;142:312-17.
30. Kropf J, Schurek JO, Wollner A, Gressner AM. Immunological measurement of transforming growth factor-beta 1 (TGF-beta1) in blood: assay development and comparison. Clin Chem 1997;43:1965-74.
31. Eppley BL, Woodell JE, Higgins J. Platelet quantification and growth factor analysis from platelet-rich plasma: implications for wound healing. Plast Reconstr Surg 2004;114:1502-8.
32. Afeltra A. Treatment of rheumatoid arthritis: new therapeutic approaches with biological agents. Curr Drug Targets Immune Endocr Metabol Disord 2001;1:45-65.